NCT00386763View on ClinicalTrials.gov

Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.

PHASE3CompletedINTERVENTIONAL
Enrollment

890

Participants

Timeline

Start Date

August 31, 2006

Study Completion Date

March 31, 2007

Conditions
MalariaFalciparum
Interventions
DRUG

Artemether-lumefantrine

Trial Locations (5)

Unknown

Novartis, Benin

Novartis, Kenya

Novartis, Mali

Novartis, Mozambique

Novartis, Tanzania

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY